Research on spinal cord injury treatment enters second phase

Wednesday September 18, 2013

Often caused by whiplash from vehicular accidents, an injured spine is often associated with numerous complications. In New Haven, Connecticut, most spinal cord injury victims have sustained a weakened immune system, paralysis and bladder problems. As a result, the many of these victims are left debilitated, relying on their loved ones’ care.

Several medical professionals across the country are conducting a number of studies that aim to find a breakthrough to help spinal cord injury victims. One group, which conducted a study at Emory University Hospital, has announced recent findings. According to the findings, the first patient is in the second phase of a trial using NSI-566 neural stem cells derived from a spinal cord. This is used to treat a condition called amyotrophic lateral sclerosis or Lou Gehrig’s disease.

The second phase escalation and trial, which focuses on safety, is intended to treat up to 15 people at five different dosages. First, 12 patients will only receive injections in the cervical region of their spinal cord. The other three will be injected in both lumbar and cervical regions. The dosage will increase in both number of cells per injection and number of injections throughout the trial.

This research aims to help a large number of spinal cord injury victims in the U.S., including those who live in New Haven, Connecticut. According to researchers, they are focusing on where they believe they can have the most significant contribution to the victim’s quality of life and longevity. However, readers should be reminded that treatment for spinal cord injury is often costly.

In many cases, the spinal cord injury victim has limited financial capabilities to cover spinal cord injury treatment. Fortunately, in New Haven, Connecticut, personal injury victims can receive compensation through a lawsuit. Compensation from the negligent party, if negligence can be proved, can help pay medical costs and other expenses resulting from injuries.

Source: Nasdaq, “Neuralstem: First patient treated in Phase II of ALS stem cell trial,” Sept. 10, 2013

Get in Touch

Schedule a Free Initial Consultation

At Kennedy, Johnson, Schwab & Roberge, L.L.C., we handle all cases on a contingency fee basis. This means that we do not get paid unless and until you receive a settlement or a jury award.

Schedule a free, confidential consultation with a skilled Connecticut personal injury lawyer today.

News & insights
Meta Inc. Files Motion to Move CT Product Liability Case to MDL
News

Meta Inc. Files Motion to Move CT Product Liability Case to MDL

23

March
2023

Is It Illegal To Drive With Your Hazard Lights On?
Articles

Is It Illegal To Drive With Your Hazard Lights On?

23

March
2023

How to Handle Chemical Exposure in the Workplace
Articles

How to Handle Chemical Exposure in the Workplace

20

March
2023

Brain Injury Awareness Month: March 2023
News

Brain Injury Awareness Month: March 2023

16

March
2023

Dram Shop Laws in Connecticut
ArticlesInsights

Dram Shop Laws in Connecticut

28

February
2023

The Leading Causes of Motor Vehicle Accidents
Articles

The Leading Causes of Motor Vehicle Accidents

20

February
2023

Upcoming Bipartisan Congressional Bills Focused on Protecting Children Online
News

Upcoming Bipartisan Congressional Bills Focused on Protecting Children Online

20

February
2023

KJSR Files Suit Against Meta Platforms Inc., Snap Inc.
News

KJSR Files Suit Against Meta Platforms Inc., Snap Inc.

6

February
2023

Wrong Way Accidents: What They Are and How They Occur
Insights

Wrong Way Accidents: What They Are and How They Occur

23

January
2023

Crosswalk Laws in Connecticut
Articles

Crosswalk Laws in Connecticut

6

January
2023